Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Rank Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2430 to 2479 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rp42 homolog; squamous cell carcinoma-related oncogene. [source:refseq;acc:nm\_020640]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1108\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5283.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4846.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 1 (core-binding factor, alpha 2 subunit) (cbf-alpha 2) (acute myeloid leukemia 1 protein) (oncogene aml-1) (polyomavirus enhancer binding protein 2 alpha b subunit) (pebp2-alpha b) (pea2-alpha b) (sl3-3 enhancer factor 1 alpha b subunit) (sl3/akv core-binding factor alpha b subunit). [source:swissprot;acc:q01196]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2877\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2692\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4095.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4113.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 3 (core-binding factor, alpha 3 subunit) (cbf-alpha 3) (acute myeloid leukemia 2 protein) (oncogene aml-2) (polyomavirus enhancer binding protein 2 alpha c subunit) (pebp2-alpha c) (pea2-alpha c) (sl3-3 enhancer factor 1 alpha c subunit) (sl3/akv core-binding factor alpha c subunit). [source:swissprot;acc:q13761]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3208\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1895\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6252.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5882.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.063\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ruvb-like 2 (ec 3.6.1.-) (48-kda tata box-binding protein-interacting protein) (48-kda tbp-interacting protein) (tip49b) (repressing pontin 52) (reptin 52) (51 kda erythrocyte cytosolic protein) (ecp-51) (tip60-associated protein 54-beta) (tap54-beta) (cgi-46). [source:swissprot;acc:q9y230]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1899\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6149.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5786.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
390\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rwd domain containing 1; ptd013 protein; cgi-24 protein. [source:refseq;acc:nm\_015952]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3073\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1034\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6732.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6152.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09414\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1027\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6700.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6123.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4301.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3729.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
144\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4362.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3349.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 1 (zinc finger protein sall1) (spalt-like transcription factor 1) (hsal1). [source:swissprot;acc:q9nsc2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2286\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 2 (zinc finger protein sall2) (hsal2). [source:swissprot;acc:q9y467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2276\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.69\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 3 (zinc finger protein sall3) (hsall3). [source:swissprot;acc:q9bxa9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2277\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.72\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 4 (zinc finger protein sall4). [source:swissprot;acc:q9ujq4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2287\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.7\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
salivary proline-rich protein po (allele k) [contains: peptide p-d] (fragment). [source:swissprot;acc:p10162]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1921\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6652.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6262.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0623\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sam domain and hd domain-containing protein 1 (dendritic cell-derived ifng-induced protein) (dcip) (monocyte protein 5) (mop-5). [source:swissprot;acc:q9y3z3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3124\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
736\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
schwannomin interacting protein 1. [source:refseq;acc:nm\_014575]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2900\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
scratch; scratch 1. [source:refseq;acc:nm\_031309]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
918\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8001.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7281.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09888\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1985\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5844.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5516.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05936\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
scy1-like 1; telomerase regulation-associated protein; ht019 protein; telomerase regulation-associated protein; n-terminal kinase-like protein; teratoma-associated tyrosine kinase; n-terminal kinase-like. [source:refseq;acc:nm\_020680]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1058\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
772\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sec23-interacting protein p125; phospholipase. [source:refseq;acc:nm\_007190]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3097\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
secreted modular calcium-binding protein 1. [source:refseq;acc:nm\_022137]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1553\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6302.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5875.75\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07267\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
secreted modular calcium-binding protein 2; smooth muscle associated protein 2. [source:refseq;acc:nm\_022138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1555\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1082\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7031.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.35\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.092\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1081\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
781\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sedlin. [source:swissprot;acc:o14582]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
350\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
20483.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17396.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17745\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
308\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5966.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4977.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19878\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-2 (dishevelled-2) (dsh homolog 2). [source:swissprot;acc:o14641]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5966.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4977.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19855\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-3 (dishevelled-3) (dsh homolog 3). [source:swissprot;acc:q92997]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
311\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5964.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4981.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19734\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
558\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
555\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
semaphorin 6b precursor (semaphorin z) (sema z). [source:swissprot;acc:q9h3t3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2832\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
semaphorin 6c precursor (semaphorin y) (sema y). [source:swissprot;acc:q9h3t2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2933\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
semaphorin 6d isoform 3 precursor. [source:refseq;acc:nm\_153617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2964\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
senescence marker protein-30 (smp-30) (regucalcin) (rc). [source:swissprot;acc:q15493]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2687\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3972.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3953.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00475\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sentrin-specific protease 8 (ec 3.4.22.-) (sentrin/sumo-specific protease senp8) (cysteine protease fksg8). [source:swissprot;acc:q96ld8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2843\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
seprase (ec 3.4.21.-) (fibroblast activation protein alpha) (integral membrane serine protease) (170-kda melanoma membrane-bound gelatinase). [source:swissprot;acc:q12884]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
931\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6194.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
septin 1 (larp) (serologically defined breast cancer antigen ny-br- 24). [source:swissprot;acc:q8wyj6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
346\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16780.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14229.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17931\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
septin 10 isoform 1. [source:refseq;acc:nm\_144710]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
327\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19094.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16067.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18839\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
septin 4 (peanut-like protein 2) (brain protein h5) (cell division control-related protein 2) (hcdcrel-2) (bradeion beta) (ce5b3 beta) (cerebral protein-7) (hucep-7). [source:swissprot;acc:o43236]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
334\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17655.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14924.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
18957.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15959.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1878\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
septin 7 (cdc10 protein homolog). [source:swissprot;acc:q16181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
329\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19007.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15999.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18801\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/